Multidrug Resistance Protein (Mdr)-alkaline Phosphatase Hybrids in Escherichia coli Suggest a Major Revision in the Topology of the C-terminal Half of Mdr (*)

Recent studies reveal that the organization of the multidrug resistance protein (Mdr) in the membrane is probably not exactly as predicted from hydropathy profiling. When expressed in Escherichia coli, phoA gene fusions can be utilized to study the membrane topology of Mdr. Using this approach, it was proposed recently that the N-terminal hydrophobic domain of Mdr spans the membrane six times, in a different fashion from that predicted by hydropathy analysis (Bibi, E. and Béj, O. (1994) J. Biol. Chem. 269, 19910-19915). In this study, we analyze [Abstract] mdr-phoA fusions constructed in the C-terminal half of Mdr. Overall, the results presented here lead to a significant revision in the membrane topology model of the C-terminal half of Mdr. The new topology is discussed with regard to the hydropathy profiles of the well characterized ABC proteins MalG and MalF, which are strikingly similar to those of the N- and C-terminal halves of Mdr, respectively.

[1]  O. Béjà,et al.  Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. , 1994, The Journal of biological chemistry.

[2]  V. Ling,et al.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. , 1991, The Journal of biological chemistry.

[3]  J. Beckwith,et al.  Genetic analysis of membrane protein topology by a sandwich gene fusion approach. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Willingham,et al.  P‐glycoprotein epitope mapping. I. Identification of a linear human‐specific epitope in the fourth loop of the P‐glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi‐drug‐resistant cells , 2007, International journal of cancer.

[5]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[6]  T. Tsuruo,et al.  Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. , 1993, The Journal of biological chemistry.

[7]  I. Pastan,et al.  The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.

[8]  J. Beckwith,et al.  Gene fusion analysis of membrane protein topology: a direct comparison of alkaline phosphatase and beta-lactamase fusions , 1994, Journal of bacteriology.

[9]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[10]  M. Cianfriglia,et al.  Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents. , 1994, Anti-cancer drugs.

[11]  H. Nikaido.  Maltose transport system of Escherichia coli: An ABC‐type transporter , 1994, FEBS letters.

[12]  S. Akiyama,et al.  Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. , 1989, The Journal of biological chemistry.

[13]  J. Beckwith,et al.  Analysis of the topology of a membrane protein by using a minimum number of alkaline phosphatase fusions , 1993, Journal of bacteriology.

[14]  V. Lingappa,et al.  Evidence for an alternate model of human P-glycoprotein structure and biogenesis. , 1993, The Journal of biological chemistry.

[15]  J. Thorner,et al.  Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells. , 1989, The EMBO journal.

[16]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[17]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[18]  R. Welch,et al.  Nucleotide sequence of an Escherichia coli chromosomal hemolysin , 1985, Journal of bacteriology.

[19]  A. Varshavsky,et al.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein , 1989, Nature.

[20]  V. Ling,et al.  Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.

[21]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[22]  P. Gros,et al.  Functional expression of mouse mdr1 in Escherichia coli. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  V. Ling,et al.  Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. , 1993, The Journal of biological chemistry.

[24]  M. Chao,et al.  Receptors for nerve growth factor. , 1992, International review of cytology.

[25]  Michael J. Hartshorn,et al.  Structural model of ATP-binding proteing associated with cystic fibrosis, multidrug resistance and bacterial transport , 1990, Nature.

[26]  D. Clarke,et al.  Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis. , 1994, The Journal of biological chemistry.

[27]  H. Theorell.  Function and structure of liver alcohol dehydrogenase. , 1967, Harvey lectures.

[28]  S. Holbrook,et al.  Structural model of the nucleotide-binding conserved component of periplasmic permeases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Finkelstein,et al.  Identification of a translocated protein segment in a voltage-dependent channel , 1994, Nature.

[30]  J. Beckwith,et al.  TnphoA: a transposon probe for protein export signals. , 1985, Proceedings of the National Academy of Sciences of the United States of America.